Skip to content

Percutaneous Nephrolithotomy Without a Ureteral Catheter

A Comparative Study of Retrograde Ureteral Catheter Insertion or Not in Percutaneous Nephrolithotomy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05598671
Enrollment
200
Registered
2022-10-28
Start date
2022-11-03
Completion date
2025-02-01
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Calculi, Nephrolithotomy Percutaneous

Brief summary

Conventional Percutaneous nephrolithotomy (PCNL) surgery requires the patient to first undergo retrograde transurethral ureteroscopic insertion of the ureteral catheter in the lithotomy position, and then change the patient to the prone position. However, repeated operation on the ureter can bring about immediate and long-term negative effects, such as ureteral false way formation, ureteral damage, perforation, avulsion, catheter insertion into the vena cava, pricking the kidney, increased postoperative pain, urinary extravasation, scar formation, and ureteral narrowing. The study planned to perform the operation in the prone position without reverse insertion of a ureteral catheter in the PCNL surgery.

Detailed description

The purpose of this single-center, single-blind, randomized trial was to evaluate the safety and efficacy of PCNL without reverse insertion of a ureteral catheter. It is planned to start in November 2022 and is expected to end in November 2024. Based on inclusion and exclusion criteria, 200 subjects were expected to be recruited. In a parallel group design, subjects were randomly assigned to two groups: the experimental group received PCNL without reverse insertion of a ureteral catheter , and the control group received traditional PCNL. The primary end point of the study was the incidence of postoperative complications according to the modified Clavien-Dindo complication grading system. Secondary end points included Stone-free rate, operation time, length of hospital stay, and medical costs. Measurement data were expressed as mean ± standard deviation (X ± S), and Student's t-test was used for intergroup comparisons. The counting data were expressed as frequency and percentage, and the chi-squared or Fisher's exact probability test were used for intergroup comparisons. The rank-sum test was used for grade data. P\<0.05 was considered statistically significant.

Interventions

PROCEDUREPCNL without reverse insertion of a ureteral catheter

The ureteral catheter was not retrograde inserted during PCNL

Sponsors

The First Affiliated Hospital of University of South China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

· Patients with upper urinary tract stones who were 18 years of age or older and eligible for PCNL surgery.

Exclusion criteria

* patients with infectious calculi confirmed by preoperative CT examination and blood biochemical indexes. * Patients with severe cardiac and pulmonary insufficiency, coagulation dysfunction and other obvious surgical contraindications. * Patients with previous history of PCNL surgery on the affected side or nephrotomy. * Patients with indwelling double J tube or nephrostomy tube before operation. * Patients with renal trauma or congenital anomalies of urinary system.

Design outcomes

Primary

MeasureTime frameDescription
Serum creatinine change valueDay 2 before surgery、Hour 3 after the surgeryThe change value of Serum creatinine between preoperative and postoperative
Neutrophils granulocyte change valueDay 2 before surgery、hour 3 after the surgeryThe change value of Neutrophils granulocyte between preoperative and postoperative
Hemoglobin change valueDay 2 before surgery、hour 3 after the surgeryThe change value of Hemoglobin between preoperative and postoperative
Hematocrit change valueDay 2 before surgery、hour 3 after the surgeryThe change value of Hematocrit between preoperative and postoperative
Rate of renal subcapsular hematomaDay 2 after the surgeryThe proportion of postoperative renal subcapsular hematoma in all patients
Rate of hydrothoraxDay 2 after the surgeryHydrothorax appeared on the surgical side.
visual analog scale (VAS)pain scoreHour 2 after the surgery0: no pain; Less than 3 points: mild pain, tolerable; 4 points to 6 points: the patient's pain and affect sleep, still tolerable; 7-10: Patients have increasing pain, pain is unbearable, affect appetite, affect sleep.
Rate of feverFrom the day of surgery to the day of discharge, up to 2 weeks.Fever was defined as axillary temperature greater than 38.5 ° C.
White blood cell count change valueDay 2 before surgery、hour 3 after the surgeryThe change value of White blood cell count between preoperative and postoperative

Secondary

MeasureTime frameDescription
Medical costs2 weeks after surgeryAll medical expenses incurred to treat stones.
Stone free rateDay 2 after the surgeryResidual stone less than 4mm in diameter was considered to have been cleared.
Operation timeDuring the procedureOperation time was defined as the time required from the surgeon's handwashing to the completion of surgical incision suture
length of hospital stay2 weeks after surgeryLength of hospital stay indicated the number of days between the operation date and discharge date

Countries

China

Contacts

Primary ContactMingyong Li, MD.
myli1123@126.com137-8648-4606

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026